🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, open-label, single-center prospective phase II study ...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2018-01-24
Trial ID
NCT03485027
Treatments Being Tested
This is a non-profit phase II, open, clinical study of the combination of i...
Status
Recruiting
Location
Beijing Hospital
Start Date
2024-03-01
Trial ID
NCT06321081
Treatments Being Tested
This observational study aims to comprehensively characterize immune-relate...
Status
Recruiting
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Start Date
2023-01-01
Trial ID
NCT07453342
Treatments Being Tested
The FIRE-4 study aims to define a treatment concept for patients with RAS w...
Status
Completed
Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Start Date
2015-03
Trial ID
NCT02934529
This study is a phase II, open-label, multicenter clinical trial designed t...
Status
Not Yet Recruiting
Location
Azienda Ospedaliero Universitaria "SS Antonio e Biagio e Cesare Arrigo"
Start Date
2026-03-30
Trial ID
NCT07381764
Treatments Being Tested
This is an open-label, multi-center, phase II trial to evaluate the safety ...
Status
Unknown
Location
Eye and ENT Hospital of Fudan University
Start Date
2019-04-15
Trial ID
NCT04921995
Treatments Being Tested
This pilot phase 2 study evaluates the effectiveness and safety of the Rech...
Status
Unknown
Location
Saint Petersburg State University Hospital
Start Date
2024-03-25
Trial ID
NCT06362694
Treatments Being Tested
The investigators hypothesize that the epigenetic agent valproic acid impro...
Status
Recruiting
Location
AORN Sant'Anna e San Sebastiano
Start Date
2025-03-12
Trial ID
NCT06714357
Treatments Being Tested
Primary Objective: * To demonstrate that re-challenge with an oxaliplatin ...
Status
Withdrawn
Location
Sanofi-Aventis Administrative Office
Start Date
2009-10
Trial ID
NCT00988897
Treatments Being Tested
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER-1 and HER...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-09-15
Trial ID
NCT05346861
Treatments Being Tested